Literature DB >> 1748476

Anti-TNF monoclonal antibodies prevent haemorrhage-induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression.

W Ertel1, M H Morrison, A Ayala, M M Perrin, I H Chaudry.   

Abstract

Kupffer cells (KC), by virtue of their ability to present antigen (AP) and express major histocompatibility complex (MHC) class II antigen (Ia), play a pivotal role in the host defence system against invading micro-organisms. Although haemorrhagic shock depresses the above KC functions, it is not known whether increased KC tumour necrosis factor (TNF) production and elevated TNF plasma levels following haemorrhage are responsible for it. To study this, C3H/HeN mice were pretreated intraperitoneally with either anti-murine TNF antibody (anti-TNF Ab) or saline. Twenty hours later mice were bled and maintained at a mean blood pressure of 35 mmHg for 60 min followed by adequate fluid resuscitation. Two and 24 hr later, plasma was collected and KC were isolated. AP was measured by co-culturing KC with the D10.G4.1 Th cell clone. Ia expression was determined by direct immunofluorescence. Interleukin (IL)-1, IL-6 and TNF levels in KC supernatants and plasma were measured with bioassays or ELISA. Haemorrhage increased circulating TNF levels by 215% at 2 hr and by 76% at 24 hr (P less than 0.05), which was prevented by pretreatment with anti-TNF Ab. Haemorrhage-induced increase of circulating IL-6 was abolished (P less than 0.05) at 2 hr but not at 24 hr in the anti-TNF Ab group. The suppression of KC AP (P less than 0.05) and Ia expression (P less than 0.05) due to haemorrhage was attenuated (P less than 0.05) in anti-TNF Ab-treated mice at 2 and 24 hr and KC IL-1 and TNF synthesis was further (P less than 0.01) increased. These results indicate that TNF plays a critical role in the initiation and regulation of KC AP, Ia expression, and cytokine production following haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748476      PMCID: PMC1384607     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.

Authors:  R Philip; L B Epstein
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

2.  Effects of interferon-gamma and tumor necrosis factor-alpha on the expression of an Ia antigen on a murine macrophage cell line.

Authors:  R J Chang; S H Lee
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

3.  Prostaglandins as endogenous mediators of interleukin 1 production.

Authors:  S L Kunkel; S W Chensue; S H Phan
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

4.  Examination of macrophage cell surface antigen regulation by rIFN-gamma and IFN-alpha/beta utilizing digital imaging by a novel laser detection system. Anchored cell analysis station (ACAS) 470.

Authors:  M M Hogan; P Y Perera; S N Vogel
Journal:  J Immunol Methods       Date:  1989-09-29       Impact factor: 2.303

5.  IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

Authors:  D M Jablons; J J Mulé; J K McIntosh; P B Sehgal; L T May; C M Huang; S A Rosenberg; M T Lotze
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

6.  Immune enhancement by tumor necrosis factor-alpha improves antibiotic efficacy after hemorrhagic shock.

Authors:  D H Livingston; M A Malangoni; G Sonnenfeld
Journal:  J Trauma       Date:  1989-07

Review 7.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

8.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

9.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.

Authors:  S L Kunkel; M Spengler; M A May; R Spengler; J Larrick; D Remick
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

10.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  5 in total

Review 1.  Helping prometheus: liver protection in acute hemorrhagic shock.

Authors:  Nils T Veith; Tina Histing; Michael D Menger; Tim Pohlemann; Thomas Tschernig
Journal:  Ann Transl Med       Date:  2017-05

2.  Macrophage-produced IL-12p70 mediates hemorrhage-induced damage in a complement-dependent manner.

Authors:  Diana J Hylton; Sara M Hoffman; N Van Rooijen; Stephen Tomlinson; Sherry D Fleming
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

3.  The release of transforming growth factor-beta following haemorrhage: its role as a mediator of host immunosuppression.

Authors:  A Ayala; D R Meldrum; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

4.  Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription.

Authors:  X Zhu; W Ertel; A Ayala; M H Morrison; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

Review 5.  Clinical review: immunodepression in the surgical patient and increased susceptibility to infection.

Authors:  Martin K Angele; Eugen Faist
Journal:  Crit Care       Date:  2002-05-24       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.